Skip to main content
SpringerLink
Log in

Lebensqualität in der Uroonkologie

  • Living reference work entry
  • First Online:
Uroonkologie

Part of the book series: Springer Reference Medizin ((SRM))

  • 21 Accesses

Zusammenfassung

Lebensqualität (LQ) ist nach der Überlebenszeit das wichtigste Behandlungsziel für Krebspatienten. Dies gilt von der Diagnosestellung an für den gesamten Krankheits- und Behandlungsverlauf. Für Patienten mit nicht malignen bzw. nicht lebensbedrohlichen Erkrankungen sind Lebensqualität oder spezifische Aspekte davon zum Teil sogar primäre Therapieziele.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Aaronson NK, Ahmedzai S, Bergman B (1993) The European organization for research and treatment of cancer. QLQ C-30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  Google Scholar 

  • Andel G van, van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D’Haese S, Aaronson NK (2008) An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer;44(16):2418–2424.

    Google Scholar 

  • Bestmann B, Rohde V, Siebmann JU, Galalae R, Weidner W, Kuchler T (2006) Validation of the German prostate-specific module. World J Urol 19:1–7

    Google Scholar 

  • Boeckmann W, Jackse G (2001) Nierenzellkarzinom. In: Rübben H (Hrsg) Uroonkologie. Springer, Berlin/Heidelberg

    Google Scholar 

  • Bullinger M (1995) German translation and psychometric testing of the SF-36 health survey: preliminary results from the IQOLA project. International quality of life assessment. Soc Sci Med 41(10):1359–1366

    Article  CAS  Google Scholar 

  • Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J et al (1993) The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 11(3):570–579

    Article  CAS  Google Scholar 

  • Dahl AA, Mykletun A, Fossa SD (2005) Quality of life in survivors of testicular cancer. Urol Oncol 23(3):193–200. Review

    Article  Google Scholar 

  • Davis JW, Kuban DA, Lynch DF, Schellhammer PF (2001) Quality of life after treatment for localized prostate cancer: differences based on treatment modality. J Urol 166(3):947–952

    Article  CAS  Google Scholar 

  • Efficace F, Bottomley A, Osoba D, Gotay C, Flechtner H, D’haese S, Zurlo A (2003) Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials – does HRQOL evaluation inprostate cancer research inform clinical decision making? J Clin Oncol 21(18):3502–3511

    Article  Google Scholar 

  • EMEA (Hrsg) (2005) Reflection paper on the regulatory guidance for the use of healthrelated quality of life (HRQL) measures in the evaluation of medical products

    Google Scholar 

  • EORTC Genitourinary Group. http://www.eortc.be/gugroup. Zugegriffen am 01.11.2018

  • FDA Guidance for Industry -Patient-Reported Outcomes Measures: LASIK quality of life collaboration project, FDA 09/27/2018

    Google Scholar 

  • Fegg MJ, Gerl A, Vollmer TC, Gruber U, Jost C, Meiler S, Hiddemann W (2003) Subjektive quality of life and sexual functioning after germ-cell tumour therapy. Br J Cancer 89(12):2002–2006

    Article  Google Scholar 

  • Fleer J, Hoekstra HJ, Sleijfer DT, Hoekstra-Weebers JEHM (2004) Quality of life of survivors of testicular germ cell cancer. Support Care Cancer 12:476–486

    Article  CAS  Google Scholar 

  • Fossa SD, de Wit R, Roberts T, Wilkinson PT, de Mulder PHM, Mead GM, Cook P, de Prijk L, Stenning S, Aaronson NK, Bottomley A, Colette L (2003) Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European organization for research and treatment of cancer genitourinary group/ medical research cuncil testicular cancer study group (30941/TE20). J Clin Oncol 21(6):1107/1118

    Article  Google Scholar 

  • Fosså SD, Oldenburg J, Dahl AA (2009) Short- and long-term morbidity after treatment for testicularcancer. BJU Int 104(9 Pt B):1418–1422

    Article  Google Scholar 

  • Fulmer BR, Bissonette EA, Petroni GR, Theodorescu D (2001) Prospective assessment of voiding and sexual function after treatment for localized prostate carcinoma: comparison of radical prostatectomy to hormonobrachytherapy with and without external beam radiotherapy. Cancer 91(11):2046–2055

    Article  CAS  Google Scholar 

  • Grimison PS, Stockler MR, Thomson DB, Olver IN, Harvey VJ, Gebski VJ, Lewis CR, Levi JA, Boyer MJ, Gurney H, Craft P, Boland AL, Simes RJ, Toner GC (2010) Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial. J Natl Cancer Inst 102(16):1253–1262. Epub 2010 Jul 14

    Article  CAS  Google Scholar 

  • Henrich G, Herschbach P (2000) Articles – Questions on life satisfaction (FLZM) – a short questionnaire for assessing subjective quality of life. Eur J Psychol Assess 16(3):150–159

    Article  Google Scholar 

  • Herden J, Ansmann L, Ernstmann N, Schnell D, Weißbach L (2016) „Therapie des lokal begrenzten Prostatakarzinoms im deutschen Versorgungsalltag“ – Eine multizentrische, prospektive Beobachtungsstudie (HAROW) mit 2957 Patienten. DÄB 113(19):329–336

    Google Scholar 

  • Herrmann E, Bierer S, Wülfing C (2010) Update on systemic therapies of metastatic renal cell carcinoma. World J Urol 28:303–309. https://doi.org/10.1007/s00345-010-0519-5

  • Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms Version 5.0 – April 2018 AWMF- Registernummer: 043/022OL

    Google Scholar 

  • IQWiG Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (Hrsg) Allgemeine Methoden Version 4.0 vom 23.09.2011. https://www.iqwig.de/download/IQWiG_Methoden_Version_4_0.pdf. Zugegriffen am 01.11.2018

  • Krupski T, Petroni GR, Bissonette EA, Theodorescu D (2000) Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinicall localized prostate cancer. Urology 55(5):736–742

    Article  CAS  Google Scholar 

  • Küchler T, Schreiber HW (1989) Lebensqualität in der Allgemeinchirurgie – Konzepte und praktische Möglichkeiten der Messung. HÄB 43:246–250

    Google Scholar 

  • Lebeau T, Perrotte P, Valiquette L, Benard F, McCormack M, Saad F, Karakiewicz PI (2005) Validation of prostate cancer index and SF-12 short forms. Can J Urol 12(6):2873–2879

    PubMed  Google Scholar 

  • Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH (1998) The UCLA prostate cancer index: development, reliability, and validity of a health-related quality of life measure. Med Care 36(7):1002–1012

    Article  CAS  Google Scholar 

  • Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM (1999) Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the prostate strategic urologic research endeavor. Urology 54(3):503–508

    Article  CAS  Google Scholar 

  • McCammon KA, Kolm P, Main B, Schellhammer PF (1999) Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 54(3):509–516

    Article  CAS  Google Scholar 

  • Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Miller HC, Oesterling JE, Resnick MI, Smalley SR et al (1995) Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. Am Urol Assoc J Urol 154(6):2144–2148

    CAS  Google Scholar 

  • Negrier S, Perol D, Ravaud A, Chevreau C, Bay JO, Delva R, Sevin E, Caty A, Escudier B (2007) Medroxyprogesterone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results of a randomized controlled trial. Cancer 110(11):2468–2477

    Google Scholar 

  • Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M (2010) Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. J Clin Oncol 28(31):4687–4696

    Article  Google Scholar 

  • Preiß J, Dornoff W, Hagmann FG, Schmieder A (2004) Onkologie 2004/2005 – Interdisziplinäre Empfehlungen zur Therapie, 12. Aufl. Zuckschwerdt, München/Wien/New York

    Google Scholar 

  • RKI (2006) www.krebsdaten.de/Krebs/DE/Content/Publikationen/Krebs_in_Deutschland/kid_2018/kid_2018_c61_prostata.pdf?__blob=publicationFile. Zugegriffen am 01.11.2018

  • Rossi SH, Klatte T, Stewart GD (2018) Quality of life outcomes in patients with localised renal cancer: a literature review. World J Urol 36(12):1961–1972. https://doi.org/10.1007/s00345-018-2415-3. Epub 2018 Jul 26

    Article  PubMed  PubMed Central  Google Scholar 

  • Sparano F, Aaronson NK, Cottone F, Piciocchi A, La Sala E, Anota A, Deliu N, Kieffer JM (2019) Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? J Comp Eff Res 8(5):279–288

    Article  Google Scholar 

  • Spilker B (Hrsg) (1996) Quality of life and pharmacoeconomics in clinical trials. Lippincott-Raven, Philadelphia

    Google Scholar 

  • Stockler MR, Osoba D, Corey P, Goodwin PJ, Tannock IK (1999) Convergent discriminitive, and predictive validity of the prostate cancer specific quality of life instrument (PROSQOLI) assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module. European organisation for research and treatment of cancer. Core quality of life questionnaire. J Clin Epidemiol 52(7):653–666

    Article  CAS  Google Scholar 

  • Tamburini M, Filiberti A, Barbieri A, Zanoni F, Pizzocaro G, Barletta L, Ventafridda V (1989) Psychological aspects of testis cancer therapy: a prospective study. J Urol 142:1487–1489

    Article  CAS  Google Scholar 

  • Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–831

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Versorgungsmanagement Entwicklung, Techniker Krankenkasse, Hamburg, Deutschland

    Beate Bestmann

  2. Allgemein- und Thoraxchirurgie, Klinikum der Christian-Albrechts-University, Kiel, Deutschland

    Thomas Küchler

Authors
  1. Beate Bestmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas Küchler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Küchler .

Editor information

Editors and Affiliations

  1. Helios Marien Klinikum Duisburg, Duisburg, Nordrhein-Westfalen, Deutschland

    Herbert Rübben

  2. Caritaskrankenhaus St. Josef, Regensburg, Deutschland

    Maximilian Burger

  3. Klinik und Poliklinik für Urologie, Universitätsklinikum Jena, Jena, Thüringen, Deutschland

    Marc-Oliver Grimm

  4. Urologische Klinik/Poliklinik, Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Deutschland

    Oliver Hakenberg

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Bestmann, B., Küchler, T. (2020). Lebensqualität in der Uroonkologie. In: Rübben, H., Burger, M., Grimm, MO., Hakenberg, O. (eds) Uroonkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-54652-9_2-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-54652-9_2-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-54652-9

  • Online ISBN: 978-3-662-54652-9

  • eBook Packages: Springer Referenz Medizin

Publish with us

Policies and ethics

Search

Navigation